Table 1 Patient characteristics
|  | DM only (n = 232,592) | Gout only (n = 71,755) | DM and gout (n = 23,261) | Neither DM nor gout (n = 1,010,893) |
|---|---|---|---|---|
Male sex | 97,041 | 48,305 | 13,192 | 395,608 |
(41.7%) | (67.3%) | (56.7%) | (39.1%) | |
Age group, years | ||||
 ≤ 50 | 41,844 | 7910 | 1616 | 395,186 |
(18.0%) | (11.0%) | (7.0%) | (39.1%) | |
 51–60 | 43,982 | 7589 | 3057 | 125,502 |
(18.9%) | (10.6%) | (13.1%) | (12.4%) | |
 61–65 | 30,762 | 6268 | 2611 | 78,983 |
(13.2%) | (8.7%) | (11.2%) | (7.8%) | |
 66–70 | 40,974 | 14,044 | 5066 | 121,976 |
(17.6%) | (19.6%) | (21.8%) | (12.1%) | |
 71–75 | 30,601 | 12,055 | 4392 | 97,567 |
(13.2%) | (16.8%) | (18.9%) | (9.7%) | |
 76–80 | 22,807 | 10,386 | 3227 | 82,298 |
(9.8%) | (14.5%) | (13.9%) | (8.1%) | |
 > 80 | 21,620 | 13,501 | 3292 | 108,785 |
(9.3%) | (18.8%) | (14.2%) | (10.8%) | |
Race | ||||
 Asian | 6533 | 3270 | 970 | 24,744 |
(2.8%) | (4.6%) | (4.2%) | (2.5%) | |
 Black | 34,551 | 10,358 | 4548 | 118,867 |
(14.9%) | (14.4%) | (19.6%) | (11.8%) | |
 Hispanic | 14,100 | 1938 | 557 | 70,382 |
(6.1%) | (2.7%) | (2.4%) | (7.0%) | |
 Other | 4199 | 934 | 470 | 11,254 |
(1.8%) | (1.3%) | (2.0%) | (1.1%) | |
 Missing | 27,372 | 6418 | 1258 | 222,928 |
(11.8%) | (8.9%) | (5.4%) | (22.1%) | |
 White | 145,837 | 48,837 | 15,458 | 562,718 |
(62.7%) | (68.1%) | (66.5%) | (55.7%) | |
Comorbidities | ||||
 Hypertension | 168,155 | 47,446 | 19,556 | 273,828 |
(72.3%) | (66.1%) | (84.1%) | (27.1%) | |
 COPD | 20,835 | 5837 | 2376 | 50,610 |
(9.0%) | (8.1%) | (10.2%) | (5.0%) | |
 Chronic kidney disease | 20,078 | 9366 | 5641 | 22,791 |
(8.6%) | (13.1%) | (24.3%) | (2.3%) | |
 Peripheral vascular disease | 14,362 | 3850 | 1997 | 22,078 |
(6.2%) | (5.4%) | (8.6%) | (2.2%) | |
 Hyperlipidemia | 168,964 | 36,296 | 18,066 | 262,591 |
(72.6%) | (50.6%) | (77.7%) | (26.0%) | |